We are live on ! Find out more
ACM

Abrams Capital Management Portfolio holdings

AUM $4.64B
1-Year Est. Return 1.52%
This Fund
S&P 500
This Quarter Est. Return
-8.94%
1 Year Est. Return
-1.52%
3 Year Est. Return
+72.02%
5 Year Est. Return
+85.41%
10 Year Est. Return
+362.14%
AUM
$3.57B
AUM Growth
-$110M
Cap. Flow
+$886M
Cap. Flow %
24.8%
Top 10 Hldgs %
77.73%
Holding
20
New
1
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$836M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$46M
3
CWH icon
Camping World
CWH
+$3.38M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 26.28%
2 Consumer Discretionary 21.29%
3 Financials 15.1%
4 Communication Services 9.59%
5 Utilities 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$671M 18.77%
6,752,869
– –
LAD icon
2
Lithia Motors
LAD
$7.78B
$304M 8.52%
2,300,000
– –
BEN icon
3
Franklin Resources
BEN
$16.9B
$282M 7.9%
9,772,486
– –
PCG icon
4
PG&E
PCG
$47.8B
$250M 7%
25,000,000
– –
AABA
5
DELISTED
Altaba Inc
AABA
$246M 6.9%
+12,650,000
New +$836M
UHAL icon
6
U-Haul Holding Co
UHAL
$14B
$219M 6.13%
5,612,580
– –
WTW icon
7
Willis Towers Watson
WTW
$27.9B
$214M 6%
1,109,811
– –
ORLY icon
8
O'Reilly Automotive
ORLY
$72.4B
$213M 5.96%
8,008,290
– –
ABG icon
9
Asbury Automotive
ABG
$4.19B
$195M 5.45%
1,902,528
– –
META icon
10
Meta Platforms (Facebook)
META
$1.51T
$182M 5.11%
1,024,723
– –
KMI icon
11
Kinder Morgan
KMI
$73.1B
$176M 4.92%
8,529,816
– –
TEVA icon
12
Teva Pharmaceuticals
TEVA
$35.9B
$165M 4.63%
24,046,356
+6,000,000
+33% +$46M
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$3.91T
$152M 4.24%
2,482,340
– –
TMDX icon
14
Transmedics
TMDX
$2.5B
$80.4M 2.25%
3,499,859
– –
SPH icon
15
Suburban Propane Partners
SPH
$1.23B
$70.6M 1.98%
2,988,346
– –
CWH icon
16
Camping World
CWH
$363M
$48.6M 1.36%
5,458,626
+349,818
+7% +$3.38M
SCU
17
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$43.3M 1.21%
2,223,860
– –
PACD
18
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$29M 0.81%
7,414,537
– –
AKBA icon
19
Akebia Therapeutics
AKBA
$327M
$22.2M 0.62%
5,656,462
– –
CCO icon
20
Clear Channel Outdoor Holdings
CCO
$1.23B
$8.45M 0.24%
3,354,390
– –

Similar funds

VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return

Abrams Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Abrams Capital Management held 20 positions worth $3.57B, down 3% from $3.68B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Abrams Capital Management deployed $886M of net new capital in Q3 2019, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Altaba Inc: 12,650,000 shares worth $246M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Abrams Capital Management's largest Q3 2019 buy was Altaba Inc: 12,650,000 shares worth $246M.
  • Abrams Capital Management added most to Teva Pharmaceuticals in Q3 2019, an estimated $46M increase.
  • Abrams Capital Management's ten largest holdings make up 78% of its $3.57B portfolio in Q3 2019.
  • Abrams Capital Management opened 1 new position and closed 0 in Q3 2019.
  • Abrams Capital Management's portfolio value fell 3% quarter-over-quarter to $3.57B.

Based on Abrams Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.